Benjamin J. Hindson 10x Genomics, Inc. (TXG) insider trading activity

Benjamin J. Hindson is of 10x Genomics, Inc.. Currently has a direct ownership of 432,605 shares of TXG, which is worth approximately $6.87 Million. The most recent transaction as insider was on Apr 01, 2021, when has been sold 41,666 shares (Class A Common Stock) at a price of $1.07 per share, resulting in proceeds of $44,583. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 433K

1.88% 3M change

27.28% 12M change

Total Value Held $6.87 Million

Benjamin J. Hindson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2021	BUY Exercise of conversion of derivative security	$44,583 $1.07 p/Share	41,666 Added 34.73%	78,302 Class A Common Stock
Mar 19 2021	BUY Grant, award, or other acquisition	-	11,169 Added 18.94%	47,805 Class A Common Stock
Mar 12 2021	SELL Open market or private sale	$6,541,978 $157.01 p/Share	41,666 Reduced 53.21%	36,636 Class A Common Stock
Mar 12 2021	BUY Exercise of conversion of derivative security	$40,833 $0.98 p/Share	41,666 Added 34.73%	78,302 Class A Common Stock
Feb 01 2021	SELL Open market or private sale	$5,949,787 $176.29 p/Share	33,750 Reduced 47.95%	36,636 Class A Common Stock
Jan 04 2021	SELL Open market or private sale	$4,731,750 $140.2 p/Share	33,750 Reduced 32.41%	70,386 Class A Common Stock
Dec 24 2020	BUY Exercise of conversion of derivative security	$38,101 $1.04 p/Share	36,636 Added 26.03%	104,136 Class A Common Stock

Dec 01 2020	SELL Open market or private sale	$5,127,637 $151.93 p/Share	33,750 Reduced 33.33%	67,500 Class A Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$29,700 $0.88 p/Share	33,750 Added 25.0%	101,250 Class A Common Stock
Nov 03 2020	SELL Open market or private sale	$1,738,890 $137.05 p/Share	12,688 Reduced 15.82%	67,500 Class A Common Stock
Nov 03 2020	BUY Exercise of conversion of derivative security	$11,165 $0.88 p/Share	12,688 Added 13.66%	80,188 Class A Common Stock
Nov 02 2020	SELL Open market or private sale	$2,888,232 $137.13 p/Share	21,062 Reduced 23.78%	67,500 Class A Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$18,535 $0.88 p/Share	21,062 Added 19.21%	88,562 Class A Common Stock
Oct 01 2020	SELL Open market or private sale	$4,240,688 $125.65 p/Share	33,750 Reduced 33.33%	67,500 Class A Common Stock
Oct 01 2020	BUY Exercise of conversion of derivative security	$29,700 $0.88 p/Share	33,750 Added 25.0%	101,250 Class A Common Stock

BJH

Benjamin J. Hindson

Pleasanton, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Value

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

Operation

Value

Type

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG

Account